Results support integration of antibiotic-eluting bone substitute materials, like CERAMENT G and CERAMENT V, into treatment guidelines for orthopedic infections.
The Synergy Disc trial is a multi-center, prospective, non-randomized, historically controlled study that is being conducted on 200 patients at 24 clinical sites in the U.S.